Intimation of allotment 2500 Equity shares under Rossari Employee Stock Option Plan -2019
As filed · Intimation of allotment 2500 Equity shares under Rossari Employee Stock Option Plan -2019.
EarningsNotablemateriality 68 out of 100
What happened
FactIntimation of allotment 2500 Equity shares under Rossari Employee Stock Option Plan -2019. Statutory Auditors of the Company have subjected the aforesaid results to “Limited Review” and. ROSSARI BIOTECH LIMITED.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedEarlierQ4 FY26
we should see this part of this ramp-up happening this year and a full-scale premix facility capacity enhancement in the next year.
NowQ4 FY26
The CAPEX plan for this year would be I think anything between Rs. 50 crore to Rs. 75 crore, that is the plan.
Change
FactTimeline delay
Implication
CapitSignal interpretationThe earlier statement indicated a full-scale capacity enhancement would happen next year, while the current statement suggests a delay in the CAPEX plan for this year with a specific budget range.confidence 90%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- the other capex which we have announced, they are going to come over the next, about a year or so. (management committed by H1 FY27)
- I think we should be at a level of at least twice of what we currently are. (management committed by FY25)
Evidence
- Outcome of Board Meeting held on Saturday, July 18, 2026(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q4 FY26
- Earlier statement · Q4 FY25
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%